Related references
Note: Only part of the references are listed.Gastroprotective effects of amifostine in rats treated by T-2 toxin
Vesna Jacevic et al.
TOXIN REVIEWS (2018)
Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats
Danijela Petrovic et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2018)
Toxicity of Doxorubicin (Dox) to different experimental organ systems
Arivalagan Pugazhendhi et al.
LIFE SCIENCES (2018)
Fullerenol nanoparticles prevents doxorubicin-induced acute hepatotoxicity in rats
Vesna Jacevic et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2017)
Protective effect of proanthocyanidins against doxorubicin-induced nephrotoxicity in rats
El-Sayed M. El-Sayed et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2017)
Effects of fullerenol nanoparticles and amifostine on radiation-induced tissue damages: Histopathological analysis
Vesna Jacevic et al.
JOURNAL OF APPLIED BIOMEDICINE (2016)
Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy
Danijela Karanovic et al.
PLOS ONE (2016)
Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro
Zhonghao Su et al.
SCIENTIFIC REPORTS (2015)
Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicity
Baikuntha Aryal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Prevention of Adriamycin-induced hepatic and renal toxicity in male BALB/c mice by a nutrient mixture
M. Waheed Roomi et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection
Martin Sterba et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Activity of Dexrazoxane and Amifostine Against Late Cardiotoxicity Induced by the Combination of Doxorubicin and Cyclophosphamide In Vivo
Snezana K. Bjelogrlic et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Oxidative Stress and Nucleic Acid Oxidation in Patients with Chronic Kidney Disease
Chih-Chien Sung et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Efficacy of amifostine in protection against doxorubicin-induced acute cardiotoxic effects in rats
Viktorija Dragojevic-Simic et al.
VOJNOSANITETSKI PREGLED (2013)
Doxorubicin-Induced In Vivo Nephrotoxicity Involves Oxidative Stress- Mediated Multiple Pro- and Anti-Apoptotic Signaling Pathways
Tejas S. Lahoti et al.
CURRENT NEUROVASCULAR RESEARCH (2012)
Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats
Hassan I El-Sayyad et al.
International Journal of Biological Sciences (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
The Protective Effects of Silymarin against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rats
Aleksandar Raskovic et al.
MOLECULES (2011)
Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model
Mohamed M. Sayed-Ahmed et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation
Othman A. Alshabanah et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Neuroendocrine Effects on the Heart and Targets for Therapeutic Manipulation in Heart Failure
Parminder S. Chaggar et al.
CARDIOVASCULAR THERAPEUTICS (2009)
Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan
Nevena Mihailovic-Stanojevic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Renal hemodynamics in heart failure: implications for treatment
Mark E. Rea et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2008)
Current Concepts of Neurohormonal Activation in Heart Failure Mediators and Mechanisms
Christopher S. Lee et al.
AACN ADVANCED CRITICAL CARE (2008)
Amifostine: The first selective-target and broad-spectrum radioprotector
John R. Kouvaris et al.
ONCOLOGIST (2007)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats
SY Saad et al.
PHARMACOLOGICAL RESEARCH (2001)
Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats
EH Herman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
In vitro antioxidant properties of amifostine (WR-2721, Ethyol)
F Marzatico et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
Share Paper
